$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > RATIONALE303

替雷利珠单抗|上市信息

百济神州抗PD-1抗体替雷利珠单抗获批非小细胞肺癌新适应症

替雷利珠单抗|最新研究

数据为王!替雷利珠单抗实现晚期非小细胞肺癌一二线全人群获益!
百创新药,济世惠民|填补肺鳞癌治疗空白,替雷利珠单抗实现晚期NSCLC
百济神州于2021 AACR首次披露百泽安(替雷利珠单抗)用于二/三线治疗